Literature DB >> 15351437

Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice.

Yumiko Motoi1, Masako Itaya, Hideo Mori, Yoshikuni Mizuno, Tadao Iwasaki, Hiroaki Hattori, Seichi Haga, Kazuhiko Ikeda.   

Abstract

Apolipoprotein E receptor 2 (apoER2) is a receptor for apolipoprotein E containing lipoprotein and also for Reelin. Apolipoprotein E-associated risk of developing Alzheimer's disease (AD) may be related to its binding to and clearance by cell surface receptors, including members of the low-density lipoprotein receptor family. Otherwise there is circumstantial evidence that the Reelin signaling pathway may contribute to neurodegeneration in AD. To investigate the role of apoER2 on amyloid deposition and neurodegeneration in vivo, we examined the presence of apoER2 in the brains of APP sw transgenic mice (Tg2576) using three apoER2 monoclonal antibodies. Our immunohistochemical study revealed that apoER2 was localized in fine granular structure and reactive astrocytes surrounding amyloid plaques. The double labeling immunohistochemistry revealed that this granular structure overlaps synaptophysin-positive dystrophic neurites. These findings indicate that neuronal apoER2 may play a role for amyloid deposition and neuronal degeneration in AD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351437     DOI: 10.1016/j.neulet.2004.06.081

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  9 in total

1.  PCSK9 is not involved in the degradation of LDL receptors and BACE1 in the adult mouse brain.

Authors:  Mali Liu; Guoxin Wu; Jennifer Baysarowich; Michael Kavana; George H Addona; Kathleen K Bierilo; John S Mudgett; Guillaume Pavlovic; Ayesha Sitlani; John J Renger; Brian K Hubbard; Timothy S Fisher; Celina V Zerbinatti
Journal:  J Lipid Res       Date:  2010-05-07       Impact factor: 5.922

2.  PCSK9 is present in human cerebrospinal fluid and is maintained at remarkably constant concentrations throughout the course of the day.

Authors:  Yan Q Chen; Jason S Troutt; Robert J Konrad
Journal:  Lipids       Date:  2014-05       Impact factor: 1.880

Review 3.  The role of lipoprotein receptors on the physiological function of APP.

Authors:  Timo Wagner; Claus U Pietrzik
Journal:  Exp Brain Res       Date:  2011-09-23       Impact factor: 1.972

4.  Reelin-mediated Signaling during Normal and Pathological Forms of Aging.

Authors:  Jana Doehner; Irene Knuesel
Journal:  Aging Dis       Date:  2010-06-04       Impact factor: 6.745

5.  Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.

Authors:  Christopher E Ramsden; Gregory S Keyes; Elizabeth Calzada; Mark S Horowitz; Daisy Zamora; Jahandar Jahanipour; Andrea Sedlock; Fred E Indig; Ruin Moaddel; Dimitrios Kapogiannis; Dragan Maric
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  Interaction of reelin with amyloid precursor protein promotes neurite outgrowth.

Authors:  Hyang-Sook Hoe; Kea Joo Lee; Rosalind S E Carney; Jiyeon Lee; Alexandra Markova; Ji-Yun Lee; Brian W Howell; Bradley T Hyman; Daniel T S Pak; Guojun Bu; G William Rebeck
Journal:  J Neurosci       Date:  2009-06-10       Impact factor: 6.167

Review 7.  Functional Roles of the Interaction of APP and Lipoprotein Receptors.

Authors:  Theresa Pohlkamp; Catherine R Wasser; Joachim Herz
Journal:  Front Mol Neurosci       Date:  2017-03-01       Impact factor: 5.639

8.  ApoER2 expression increases Abeta production while decreasing Amyloid Precursor Protein (APP) endocytosis: Possible role in the partitioning of APP into lipid rafts and in the regulation of gamma-secretase activity.

Authors:  Rodrigo A Fuentealba; Maria Ines Barría; Jiyeon Lee; Judy Cam; Claudia Araya; Claudia A Escudero; Nibaldo C Inestrosa; Francisca C Bronfman; Guojun Bu; Maria-Paz Marzolo
Journal:  Mol Neurodegener       Date:  2007-07-09       Impact factor: 14.195

Review 9.  Proprotein convertase subtilisin/kexin type 9: from the discovery to the development of new therapies for cardiovascular diseases.

Authors:  Nicola Ferri
Journal:  Scientifica (Cairo)       Date:  2012-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.